Medicare scrambles to keep prescription drug plan premiums stable ahead of elections

Taking stock of the drug industry, from the lab to the medicine chest

August 5, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Medicare scrambles to keep prescription drug plan premiums stable ahead of elections Federal officials are working to keep Medicare prescription drug plan premiums from jumping ahead of the election. By John Wilkerson Opinion: Diversity statements should not be required for federal STEMM grant funding Former Harvard Medical School dean Jeffrey Flier argues against requiring DEI statements for federal science research funding. By Jeffrey S. Flier Politics is holding back the best tool for treating meth addiction Offering people incentives to stop using meth, a practice known as contingency management, runs against a federal cap of $75 per year. By Lev Facher

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser